1100 13th Street, NW, Suite 750Washington, DC 20005202.887.6400Toll-free: 800.544.0155
All Contents © 2018The Kiplinger Washington Editors
Health-care stocks – and pharmaceutical makers in particular – recently dodged a bullet when President Donald Trump unveiled a relatively benign overhaul to the nation’s health-care system with...
While the foreseeable future for the broad market may not be clear, there’s one group that still moves independently of stocks as a whole — biotech stocks.
These stocks are still pushed...
These companies could be attractive acquisition candidates for Berkshire Hathaway. Buy their stocks now and beat the master to the punch.
More Investing News »